51
Participants
Start Date
January 31, 2007
Primary Completion Date
January 31, 2009
Study Completion Date
January 31, 2009
Acarbose
After an 8-week period of metformin monotherapy (500 mg t.i.d.), all patients were randomised to add on either acarbose or glibenclamide. The doses of acarbose and glibenclamide were 50 mg t.i.d. and 2.5 mg t.i.d., respectively, for 4 weeks and force-titrated to 100 mg t.i.d. and 5 mg t.i.d., respectively, for the last 12 weeks.
Taichung Veterans General Hospital, Taichung
Taipei Veterans General Hospital, Taiwan
OTHER_GOV
Changhua Christian Hospital
OTHER
Taichung Veterans General Hospital
OTHER